Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[SOCSJ gene mutations in patients with diffuse large B-cell lymphoma].

Terapevticheskii arkhiv - 1 Jan 2015

Gavrilina O A, Zvonkov E E, Biderman B V, Severina N A, Parovichnikova E N

Abstract excerpt

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of diseases, which accounts for 30% of all non-Hodgkin lymphomas. Current molecular studies have confirmed that there are several DLBCL subtypes characterized by different cellular origin, cytogenetic profile, molecular genetic disorders, and different pathogenesis. Impaired JAK-STAT signaling is a part of the pathogenesis of various cancers,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Neoplasm
Share to SOCS1 gene
Share to Lymphoma, Large B-Cell, Diffuse

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Suppressor of Cytokine Signaling Proteins

Source

Identifiers

PMID: 26390734
DOI: 10.17116/terarkh2015877105-111

Genes

SOCS1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[SOCSJ gene mutations in patients with diffuse large B-cell lymphoma].PMID 26390734Read ↗

Genetic lesions in diffuse large B-cell lymphomas.Semantic proximity Read ↗

[Genetic studies on lymphoma].Semantic proximity Read ↗

Prognostic Analysis of Diffuse Large B-Cell Lymphoma Patients Based on Clinical Characteristics, TP53 Mutation Status, and Number of Co-mutated GenesSemantic proximity Read ↗

Genetic lesions and targeted therapy in Hodgkin lymphomaSemantic proximity Read ↗

Genetic Map of Relapsed and Refractory Diffuse Large B-cell Lymphoma: A Systemic Review and Association AnalysisSemantic proximity Read ↗

Gene mutations in malignant lymphoma.Semantic proximity Read ↗

Structural analysis and conformational dynamics of SOCS1 gene mutations involved in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.Semantic proximity Read ↗

Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6.Semantic proximity Read ↗

SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients.Semantic proximity Read ↗

Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities.Semantic proximity Read ↗

Germline mutations predisposing to diffuse large B-cell lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.